middle.news

Bioxyne Surges with Record $14.1M Q1 Revenue, Eyes European Expansion

12:02pm on Thursday 30th of October, 2025 AEDT Pharmaceuticals
Read Story

Bioxyne Surges with Record $14.1M Q1 Revenue, Eyes European Expansion

12:02pm on Thursday 30th of October, 2025 AEDT
Key Points
  • Record Q1 FY26 revenue of $14.1 million, up 210% year-on-year
  • Substantial investment in cannabis flower inventory to meet European demand
  • Dual listing completed on Frankfurt Stock Exchange
  • Progress on manufacturing and regulatory approvals in UK and EU
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about BXN
OPEN ARTICLE